成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook >> journal list >> Indian Journal of Dermatology Venereology & Leprology >>article
Indian Journal of Dermatology Venereology & Leprology

Indian Journal of Dermatology Venereology & Leprology

IF: 3.2
Download PDF

Gabapentin and pregabalin in dermatology.

Published:1 September 2018 DOI: 10.4103/ijdvl.IJDVL_480_17 PMID: 29855453
Asit Mittal, Chesta Agarwal, Manisha Balai, Ayush Taneja

Abstract

History Pregabalin was synthesized in 1990 as an anticonvulsant. It was invented by Richard Bruce Silverman at Northwestern University in Chicago, Illinois. The drug was approved in the European Union in 2004. The US received Food and Drug Administration approval for use in treating epilepsy, diabetic neuropathic pain and postherpetic neuralgia in December 2004. Gabapentin was originally approved by the U.S. Food and Drug Administration in December 1993 for use as an adjuvant medication to control partial seizures in adults; that indication was extended to children in 2000. In 2004, its use for treating postherpetic neuralgia (neuropathic pain following shingles) was approved.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Pregabalin 148553-50-8 C8H17NO2 864 suppliers $44.00-$2480.00
Gabapentin 60142-96-3 C9H17NO2 834 suppliers $9.35-$775.00

Similar articles

IF:4.6

A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin.

Clinical Pharmacokinetics Howard N Bockbrader, David Wesche,etc Published: 1 October 2010
IF:11

Fusidic acid in dermatology

British Journal of Dermatology Wilkinson,etc Published: 12 January 2010
IF:2

Fusidic acid in dermatology: an updated review.

European Journal of Dermatology Helmut Sch?fer, Lene Simonsen,etc Published: 1 January 2010